MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tauopathies"

  • 2023 International Congress

    CBS presenting rapidly progressive anterior operculum syndrome with suggested background pathology of 4-repeat tauopathy by tau PET: A case report

    K. Nakamura, Y. Kuroha, M. Hatakeyama, A. Kimura, Y. Nakamura, Y. Murakami, M. Watanabe, H. Igarashi, T. Takahashi, H. Shimada (Niigata city, Japan)

    Objective: Report of a case with suspected TDP-43 proteinopathy as the pathological background in the early stage of the disease, and a final diagnosis of…
  • 2023 International Congress

    Introducing the molecular subtyping of Progressive Supranuclear Palsy: a proof of concept

    I. Martinez-Valbuena, S. Lee, E. Santamaria, J. Fernandez-Irigoyen, B. Couto, N. Reyes, H. Tanaka, S. Forrest, A. Kim, H. Qamar, J. Li, A. Karakani, K. Senkevich, E. Rogaeva, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)

    Objective: To enhance understanding of the molecular mechanisms underlying disease heterogeneity in Progressive supranuclear palsy (PSP) Background: PSP is a 4R-tauopathy characterised by subcortical pathology…
  • 2023 International Congress

    Transferrin as a possible CSF biomarker in neurodegenerative proteinopathies

    K. Mensikova, P. Kanovsky, K. Klicova, D. Konickova, S. Kurcova, M. Nevrly, P. Otruba, Z. Grambalova, M. Kaiserova, J. Zapletalova (Olomouc, Czech Republic)

    Objective: The aim of this study was to determine whether cerebrospinal fluid (CSF) levels of transferrin differ between patients with Parkinson´s disease (PD), multiple system…
  • 2023 International Congress

    Phenotypic characterization of 104 patients with Progressive Supranuclear Palsy: A Tertiary care experience from South India

    R. Yadav, S. Dey, N. Kamble, V. Holla, R. Mahale, M. Debnath, P. Pal (Bangalore, India)

    Objective: To prospectively evaluate and subtype the patients of Progressive supranuclear palsy being referred to a tertiary care movement disorders facility in South India. Background:…
  • 2023 International Congress

    Early-onset cortico-basal degeneration (CBD) due to a c.2092G>A MAPT mutation

    M. Mata Alvarez-Santullano, L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre (Madrid, Spain)

    Objective: To describe a patient with early-onset atypical parkinsonism that evolved to a classic CBD without dementia, associated to a c.2092G>A MAPT mutation Background: Although…
  • 2022 International Congress

    Complications in Patients with Progressive Supranuclear Palsy

    I. Aiba, H. Takigawa, R. Hanajima, T. Shimohata, M. Morita, K. Hasegawa, H. Kowa, M. Kanazawa, T. Tokuda, AM. Tokumaru, K. Nakashima, T. Ikeuchi (Nagoya, Japan)

    Objective: This study elucidated the incidence and features of complications in patients with progressive supranuclear palsy (PSP). Background: PSP is a progressive neurodegenerative disorder accompanied…
  • 2022 International Congress

    Pan India Registry for Progressive Supranuclear Palsy (PAIR-PSP)

    P. Kukkle, R. Gupta, S. Desai, S. Mehta, D. Joshi, N. Kumar, R. Kandadai, L. Sahoo, A. Mukherjee, V. Paramanandam, S. Murugan, D. Kp, S. Sundaram, R. Rajan, R. Menon, K. Shetty, P. Samson, S. Krishnan, M. Deshmukh, P. Wadia, C. Sandeep, P. Aggarwal, S. Bhowmick, H. Kumar, A. Biswas, V. Goyal, S. Seshagiri, R. Borgohain, V. Ramprasad (Bangalore, India)

    Objective: To understand Progressive Supranuclear palsy (PSP) phenotype and genotype from India. Background: Insights into PSP pathophysiology and newer clinical  phenotypes are  increasingly being recognized.…
  • 2022 International Congress

    Plasma p-tau181 is increased in Lewy body dementia and relates to cognitive performance

    N. Hannaway, A. Heslegrave, R. Bhome, I. Dobreva, H. Zetterberg, R. Weil (LONDON, United Kingdom)

    Objective: To compare plasma p-tau181 concentration in Parkinson’s disease (PD), Lewy body dementia (LBD) and healthy controls and to examine the relationship between ptau-181 concentration…
  • 2022 International Congress

    In-vivo measurement of tau depositions in anti-IgLON5 disease with 18F-PI2620-PET

    H. Theis, GN. Bischof, I. Ayzenberg, N. Brüggemann, T. Grüter, J. Hammes, J. Lewerenz, F. Leypoldt, A. Drzezga, T. van Eimeren (Cologne, Germany)

    Objective: The aim of the study was to examine the potential of the second-generation tau-PET tracer 18F-PI2620 to detect tau deposition in anti-IgLON5 disease. Background:…
  • 2022 International Congress

    Three patients with PSP presenting with a logopenic pattern of aphasia: expanding the phenotype of language impairment in PSP.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin, Ireland)

    Objective: To investigate the a series of cases presenting with apparent logopenic variant primary progressive aphasia who then developed symptoms suggestive of PSP. Background: Deficits…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley